Coagulation Disorders
Hematology and oncology research involve the study of blood and blood-related diseases, conditions, and cancers. One such area of study is coagulation disorders. Coagulation is the process by which blood clots to prevent excessive bleeding from injuries. However, when the blood clotting process is abnormal or impaired, it can lead to coagulation disorders. Coagulation disorders are a group of disorders that affect the body's ability to form blood clots. These disorders can be genetic or acquired, and they can range from mild to severe. Some of the most common coagulation disorders include hemophilia, von Willebrand disease, and thrombophilia. Hemophilia is an inherited bleeding disorder caused by a lack or deficiency of clotting factors. There are two types of hemophilia, A and B, which are caused by a deficiency in clotting factor VIII or IX, respectively. People with hemophilia can experience excessive bleeding and bruising, even from minor injuries. Von Willebrand disease is another inherited bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor, which is necessary for clotting. Unlike hemophilia, which affects primarily males, von Willebrand disease affects both males and females equally. Thrombophilia is a group of disorders that increase a person's risk of developing blood clots. These disorders can be genetic or acquired and can result in deep vein thrombosis, pulmonary embolism, and stroke. In conclusion, coagulation disorders are an important area of study in hematology and oncology research. The better our understanding of these disorders, the better equipped we will be to diagnose, treat, and prevent them.
← Hematology Research and Oncology Research